Trials / Completed
CompletedNCT00642681
Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Mannkind Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Technosphere Insulin | Technosphere® Insulin (TI) Inhalation Powder, prandial |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-07-01
- Completion
- 2008-08-01
- First posted
- 2008-03-25
- Last updated
- 2014-12-03
Locations
24 sites across 3 countries: United States, Canada, Russia
Source: ClinicalTrials.gov record NCT00642681. Inclusion in this directory is not an endorsement.